One of the aims of iPROMISE is to translate fundamental research into clinical practice. We focus on designing fast and easy pharmacodiagnostic products for clinical uses to allow more effective therapeutic treatments in our own setting.

We hope to be able to contribute to improve patients’ outcomes by translating pharmacogenetics knowledge. This indeed would improve the quality of health care besides minimizing the cost due to trial and error and non-targeted therapy. A number of pharmacogenomics tests have been developed in-house that have great potential for the benefit of patients and also for commercialization. Two of the test kits are being discussed and evaluated for commercialization.